Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Por um escritor misterioso
Descrição
Cancers, Free Full-Text
Nivolumab and Relatlimab for Advanced Melanoma - NCI
Double Trouble: Immunotherapy Doublets in Melanoma—Approved and Novel Combinations to Optimize Treatment in Advanced Melanoma
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study - The Lancet Oncology
Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases - Moyers - 2021 - Cancer Medicine - Wiley Online Library
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity, Journal for ImmunoTherapy of Cancer
Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastases: Quo Vadis?
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives
The forgotten role of adjuvant immune checkpoint inhibitors in preventing melanoma brain metastasis
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study - The Lancet Oncology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
